Diagnostic Tests in CLL

Opinion
Video

Dr Linhares gives a comprehensive overview of tests a patient might expect to undergo at the time of diagnosis and why they are important.

Related Videos
Video 4 - "Current First-Line Treatment Options in CLL"
Video 3 - "Goals of Treatment for Patients With CLL"
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Alicia Morgans, MD, MPH, an expert on prostate cancer
Alicia Morgans, MD, MPH, an expert on prostate cancer
Alicia Morgans, MD, MPH, an expert on prostate cancer
Alicia Morgans, MD, MPH, an expert on prostate cancer
D'Agostino in an interview with CURE
Related Content
Illustration of a woman with very curly red hair.

A Cancer Drug that Impacted My Life for SLL

April 26th 2024
Article

After reading a book about how Imbruvica was revolutionized for SLL and CLL, I now have a greater appreciation for the drugs I receive.

Read More

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

January 22nd 2024
Podcast

We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.

Listen

Image of a pill split in half with graphics of circles in the middle, symbolizing technology.

FDA Approves Easier-to-Swallow Imbruvica Formulation

February 29th 2024
Article

An oral suspension formula of Imbruvica received the green light from the Food and Drug Administration to be used in all approved indications.

Read More

CURE Talks Cancer podcast

The Treatment Journey of a Patient with CLL

December 31st 2020
Podcast

In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.

Listen

A medical professional holding a vial of a BTK inhibitor with a syringe for patients with blood cancer.

Drug Combos May Help Lower Blood Pressure in Patients Taking Imbruvica

February 6th 2024
Article

Certain antihypertensive medications may lower blood pressure in patients with blood cancer being treated with Imbruvica or other BTK inhibitors.

Read More

blood cancer cells floating. A novel CD NK therapy could benefit patients with lymphoma, CLL, SLL, mantle cell lymphoma, among others.

Cord Blood-Derived Treatment Shows Promise in Blood Cancer

January 25th 2024
Article

A CAR NK therapy made from cord blood showed promising responses in patients with relapsed or refractory B-cell malignancies.

Read More